Mpox Vaccine Acceptance, Democratic Republic of the Congo
We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.
Authors
- Megan Halbrook (ORCID: https://orcid.org/0000-0002-3892-2655)
- Jason Kindrachuk (ORCID: https://orcid.org/0000-0002-3305-7084)
- Christophe Luhata (ORCID: https://orcid.org/0009-0003-3249-2644)
- Sydney Merritt (ORCID: https://orcid.org/0000-0002-4039-605X)
- Didine Kaba (ORCID: https://orcid.org/0000-0002-3582-5147)
- Anne W. Rimoin (ORCID: https://orcid.org/0000-0002-0662-9067)
- Nicole A. Hoff (ORCID: https://orcid.org/0000-0002-1770-6304)
- Dalau Mukadi Nkamba (ORCID: https://orcid.org/0000-0002-5379-0507)
- Skylar Petrichko
- Handdy Kalengi
- Leonard Kamba
- Michael Beya
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3201/eid3012.241226
- Citations
- 10
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 5.28